, Wong, I
GLP-1 receptor agonists are proving to be a valuable resource in our psychiatric toolkit, particularly for patients struggling with binge eating disorder
Well, the research shows that people with type 2 diabetes (the most common reason to take Ozempic) are twice as likely to experience depression as people without type 2 diabetes
Weiss B, Widemann BC, Wolters P, Dombi E, Vinks A, Cantor A, et al
Foundayo (Orforglipron): As a convenient oral GLP-1 receptor agonist, Foundayo is gaining recognition for its meaningful weight loss results without specific food timing restrictions
LegitScript verifies that telehealth companies comply with healthcare regulations, including proper licensing and pharmacy standards